Evidence map›Paper›PMID 41573021›Full record

ReviewMedical acupuncture2025

Acupuncture at Neiguan Acupoint (PC6) for Coronary Heart Disease: A Scoping Review.

Jin-Huan Yue, Sheng-Lan Gao, Wei-Ran Chen, Dong-Hong Huang, Xian-Qi Zhao, Ang Li, Xiao-Ling Li, Guanhu Yang, Qin-Hong Zhang

Abstract readReview
In one paragraph

Review in Medical acupuncture, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jin-Huan YueShenzhen Frontiers in Chinese Medicine Research Co., Ltd., Shenzhen, China.
Sheng-Lan GaoDepartment of Radiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wei-Ran ChenFirst School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Dong-Hong HuangFirst School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Xian-Qi ZhaoFirst School of Clinical Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.
Ang LiServier (Beijing) Pharmaceutical Research & Development CO. Ltd., Beijing, China.
Xiao-Ling LiDivision of CT and MRI, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.
Guanhu YangDepartment of Specialty Medicine, Ohio University, Athens, Ohio, USA.
Qin-Hong ZhangShenzhen Frontiers in Chinese Medicine Research Co., Ltd., Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronary heart disease (CHD), also known as coronary artery atherosclerosis, is a highly prevalent and deadly disease worldwide, posing a serious threat to human health. There is an urgent need for more convenient and cost-effective treatment modalities to improve the symptoms and prognosis of patients. Method: This article reviews existing studies on acupuncture treatment of CHD using the Neiguan acupoint (PC6), which is documented in traditional Chinese medicine for alleviating "chest congestion" and "heartache" and is a hot topic in modern clinical research. Results: Acupuncture, particularly at PC6, has unique advantages in effectively relieving the clinical symptoms of CHD patients. Conclusions: The review aims to assist in the clinical application of PC6 acupuncture for CHD by summarizing current evidence.

Indexed as

acupunctureangina pectoriscoronary heart diseasemyocardial ischemiaNeiguan acupoint

Identifiers

PMID41573021
PMCPMC12820672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.